To ensure access to quality and affordable care for cancer patients within their communities.

 

Links:

Membership
Clinical Pathways

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon Sign up for our Email Newsletter
 
Upcoming Events

LunchTime Series Teleconference
Wednesday, July 30, 2014 from 12:00pm - 1:30pm PST  Topic: "California Regulated Medical Waste Management and Proper Waste Segregation"
Presented by:
Richard Best
Technical Director, Stericycle 

For more information and to register, email moasc@moasc.org
or call 909-985-9061 ext. 1.

If you missed the June 25th LunchTime Series presentation "Thunderclouds (and silver linings) looming out the window," presented by Dawn Holcombe, President, DGH Consulting, Executive Director, Connecticut Oncology Association, the replay is now available. The topics discussed were those that impact MOASC members, the specialty of oncology and issues on which to keep a weather eye. Topics included: USP 800;  Networks (growing and shrinking); Management of risk for oncology patients; Outpatient care bundling; Patient co-pay assistance eligibility definitions; ICD-10; Evidence libraries replacing MD decision making, and Specialty pharmacy (mandates and centers). To listen to the replay, call 888-203-1112 with password 258487865. For handouts to follow along with the recording contact the MOASC Office at moasc@moasc.org

LunchTime Series Teleconference

Wednesday, July 30th at 12:00PM-PST
Wednesday, August 27th at 12:00PM-PST
Wednesday, September 24th at 12:00PM-PST

To RSVP please email Danielle Overman at moasc@moasc.org

Save-the-date! Friday, September 19, 2014!
MOASC Nurse Program in Pasadena.
7:30am - 8:00am Registration – Breakfast – Exhibit Hall
8:00am   Welcome & Introductions
8:15am  - 9:15am Oral Adherence presented by:
Flora Woo, MSN, RN, Senior Clinical Nurse Consultant, Celgene Corporation
9:15am – 9:30am Break/Refreshments – Exhibit Hall
9:35am – 10:55am Compassion Fatigue: Building Resilience in Oncology Nurses presented by:
 Katherine Joyce Janzen RN, MN, ONC(C)
Assistant Professor, School of Nursing and Midwifery
Faculty of Health and Community Studies
Mount Royal University, Calgary, Alberta, Canada.
11:00am – 12:00pm  The Art of Active Listening (AAL) presented by:
Ms. Selinza Ann Mitchell, CNS, Oncology Clinical Nurse Educator, Pfizer Oncology
For more information and to register, email moasc@moasc.org
or call 909-985-9061 ext. 1.

Save-the-date!  Friday, November 14, 2014!
The MOASC Advisory Summit will be held at the
InterContinental Hotel in Century City.
The schedule is:
12:00pm - 5:00pm   B-Cell Advisory Board Meeting 
 (limited to 10 physicians)
3:00pm - 5:00pm     Pathways Advisory Board Meeting  (limited to 15 physicians)
3:00pm - 5:00pm  myPlan Lung Cancer Prognostic Test Advisory    (limited to 20 physicians)
5:00pm - 6:00pm     Reception - Exhibit Hall
6:30pm - 8:15pm     Dinner Program
For more information and to register, email moasc@moasc.org
or call 909-985-9061 ext. 1.This meeting precedes Research To Practice - Year In Review Program with Dr. Neil Love on
Saturday, November 15, 2014.
For more information visit: www.researchtopractice.com

 
 
 
Hot Topics

House appropriators are considering moving a continuing resolution before the August recess to fund the federal government through the first part of fiscal year 2015. House Appropriations Committee Chairman Hal Rogers (R-KY) commented that the limited time in session before the end of the current fiscal year is prompting the discussion about a stopgap spending measure. Congress adjourns for the August recess next week and won't return until Sept. 8. Without another continuing resolution before Sept. 30, the government would shut down. Click here for more information.

In a memorandum released on July 18, the Centers for Medicare & Medicaid Services (CMS) announced that rather than requiring prior authorization for all drugs, CMS is now encouraging Part D drug plans to instead require prior authorization only on analgesics, antinauseants, laxatives, and antianxiety drugs. Click here for more information.

Messaging, fact sheets and talking points for the "No On 46" campaign are now available both in print and online. These fact sheets and talking points will make up the core of r messaging with voters between now and November. Messaging will be distributed through the campaign's social media accounts on both Facebook and Twitter. You are encouraged to follow both of these accounts. Hard copies of these documents, as well as the complete campaign toolkit, can be requested through either the "No On 46" website or CMA's MICRA page. Health care practitioners also have the opportunity to request patient outreach material, including pamphlets, posters and buttons, through the providers' section of the campaign website. Click here for more information.

ASP Quarterly Drug Pricing Files and Revisions to Prior Quarterly Pricing Files - October 2014. Change Request (CR) 8836 instructs MACs to download and implement the October 2014 Average Sales Price (ASP) drug pricing files and, if released by the Centers for Medicare & Medicaid Services (CMS), the July 2014, April 2014, January 2014, and October 2013, ASP drug pricing files for Medicare Part B drugs. CR8836. Read the complete update. Click here for more information.

Physicians will receive a $100 stipend to attend a focus group at the Residence Inn Beverly Hills on August 13th , 6:00pm-8:00pm. The CMA Foundation and The Department of Health Care Services (DHCS) are going to talk with physicians about the Coordinated Care Initiative (the dual eligibles project). They need your input to better understand what physicians know about CCI, as well as their questions and concerns about CCI. The Coordinated Care Initiative (CCI), allows persons eligible for both Medicare and Medi-Cal (dual eligibles) to receive medical, behavioral, long-term supports and services and home-and community-based services through a single managed care plan in eight. Through this project, enrollment in Medi-Cal managed care is mandatory for Medi-Cal benefits. Patients will be able to "opt out" of receiving Medicare benefits through a managed care plan. The California Medical Association (CMA) Foundation is partnering with the Department of Health Care Services (DHCS) and Harbage Consulting to identify physician questions and concerns about CCI. All responses are confidential. Reports from the focus groups would be shared with DHCS and Harbage Consulting to help them develop materials that address physicians' most pressing questions. Interested physicians should be fee-for-service physicians who see patients dually eligible for Medicare and Medi-Cal or participate in a managed care plan. This a great opportunity to be involved in public policy development. With the $100 stipend, a light meal will be served. SPACE IS LIMITED-REGISTER ASAP. To register or for more information please contact Liza Trujillo Kirkland at 916.779.6643 or lkirkland@thecmafoundation.org. Click here for more information.

 
 
MOASC Information

Novartis is pleased to confirm that ZYKADIA™ (ceritinib) capsules has been approved by the US Food and Drug Administration (FDA) on April 29, 2014 and is available in a 150 mg strength. Novartis Pharmaceuticals Corporation will sell ZYKADIA (ceritinib) capsules to McKesson Specialty Care Distribution Corporation for its sale in the United States to certain specialty pharmacies and most other pharmacies excluding retail pharmacies.

  • ZYKADIA is a once-daily, oral anaplastic lymphoma kinase (ALK) inhibitor indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC), who have progressed on or who are intolerant to crizotinib. This indication is approved under accelerated approval, based on tumor response rate and duration of response.  An improvement in survival or disease-related symptoms has not been established.  Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.

Please see accompanying full Prescribing Information or visit www.ZYKADIA.com

MOASC held its Spring General Membership Meeting on May 22nd at the Queen Mary in Long Beach. In case you missed it, below is a synopsis of the evening:

Oncology Leadership Economic Conference - Roundtable discussion with the MOASC Board of Directors and Industry Partners.
Exhibitions & Networking Reception.  This meeting was sponsored in part by: BMS, Merck Oncology, Myriad, Oncology Supply and Pfizer.
Robert Moss, M.D., MOASC President welcomed all attendees and began with introductions.
Peter Yu, M.D., Director of Cancer Research, Palo Alto Medical Foundation, President, ASCO presented: "ASCO Initiatives".
Jennifer Malin, M.D., Medical Director of Oncology and Care Management, WellPoint and Sylvia Carlisle, M.D., Medical Director for Anthem presented: "California Changing Healthcare Landscape: Implications for Cancer Care".
Kathy Fairbanks, Patients and Providers to Protect Access and Contain Health Costs, the campaign to defeat the MICRA ballot measure.

 
   
     

Diamond:
Bayer Healthcare Pharmaceuticals, Cardinal Health Specialty Solutions, Lilly Oncology, Millennium
Gold:

Amgen,  Astellas Oncology, Janssen Therapeutics, Oncology Supply, Onyx Pharmaceuticals, Novartis, Sanofi Oncology

Silver:
AMAG Pharmaceuticals, AstraZeneca, Eisai,
Genentech, Genomic Health, Innovatix, McKesson Specialty Health, Merck Oncology, Myriad Pfizer, Seattle Genetics, Veridex, Myriad Genetics, Rosetta Genomics, Dendreon
Other:

BMS, Medico Specialty Pharmacy, Medivation, MedSym Solutions, Miraca Life Sciences, Navigating Cancer

 
© 2008 - 2014 Medical Oncology Association of Southern California
P.O. Box 161   •    Upland, CA 91785
Phone: (909) 985-9061   •    Fax: (909) 985-8581   •   email:
moasc@moasc.org

Open Central 

inland empire website design wow webs